Why the study?
Does the watch-and-wait approach provide similar oncological outcomes and avoid surgical morbidity compared to radical surgery in patients with rectal cancer who have a complete clinical response after neoadjuvant chemoradiation?
Does the watch-and-wait approach provide similar oncological outcomes and avoid surgical morbidity compared to radical surgery in patients with rectal cancer who have a complete clinical response after neoadjuvant chemoradiation?
Answers are grounded in this paper and cite their sources.
The watch-and-wait approach is a viable organ-preservation strategy for rectal cancer patients with a complete clinical response to neoadjuvant chemoradiation, avoiding surgical morbidity without compromising oncological outcomes.
Organ preservation is considered in the management of selected patients with rectal cancer. Complete clinical response observed after neoadjuvant chemoradiation for rectal cancer is one of these cases. Patients who present complete clinical response are candidates to the watch-and-wait approach, when radical surgery is not immediately performed and is offered only to patients in the event of a local relapse. These patients are included in a strict follow-up, and up of 70% of them will never be operated during the follow-up. This strategy is associated with similar oncological outcomes as patients operated on, and the advantage of avoiding the morbidity associated to the radical operation. In this article we will discuss in detail the best candidates for this approach, the protocol itself, and the long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Julião et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: